Atlas Trials

Stereotactic MR-Adaptive Radiation Therapy for Early-stage Renal Cancer

Clinical trial NCT07767500 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07767500
Sponsor
NYU Langone Health
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Primary Renal Cancer
Start date
2026-09-01
Primary completion
2029-10-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.